Inovio Pharmaceuticals effects 1-for-12 reverse stock split effective January 24, 2024

INOVIO PHARMACEUTICALS, INC.

Every 12 issued and outstanding shares combined into 1 share; par value unchanged at $0.001.
Fractional shares not issued; stockholders entitled to fractional shares receive cash based on Jan 24 closing price.
Authorized shares of common stock remain at 600,000,000; no reduction.
Proportionate adjustments made to stock options, Series C Convertible Preferred Stock, and equity incentive plans.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

INOVIO PHARMACEUTICALS, INC.: 1-for-12 reverse stock split of common stock effected through certificate of amendment to certificate of incorporation (effective 2024-01-24).

Change: charter amendment
Effective: 2024-01-24

Exact text from the filing

On January 24, 2024, Inovio Pharmaceuticals, Inc. (the “ Company ”) filed with the Secretary of State of the State of Delaware a certificate of amendment to its certificate of incorporation, as previously amended (the “ Charter Amendment ”) to effect a 1-for-12 reverse stock split of the Company’s common stock (the “ Reverse Stock Split ”). The Reverse Stock Split became effective at 5:00 p.m. Eastern Time on January 24, 2024.

View on SEC.gov

Browse all governance changes →

INOVIO PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-24-015380

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.